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Introduction: 
- Autism Spectrum Disorder (ASD) is a developmental 
disorder that is expected to affect 1 in 54 children in the 
United States
- The etiologic agent for autism is unknown but scientists 
suspect that environmental factors and genetics play a role.
- DEHP is a phthalate that is commonly used as a plasticizer in 
PVC to make everyday consumer goods such as raingear, 
shower curtains, and medical tubing more flexible.
- DEHP is an endocrine disrupting compound (EDC). EDC’s are 
chemicals that interfere with the metabolic activities and 
natural hormones in the body which are responsible for 
homeostasis, reproduction, or development. 
Objective
- To systematically review the literature published since 2014 
to identify if there is an association between gestational 
and/or early childhood DEHP exposure and Autism 
incidence. 
Participants: Children from 3-12 years old 
Exposure: Children with high gestational or early childhood exposure to the 
DEHP phthalate 
Comparator: Children with low gestational or early childhood DEHP 
phthalate exposure 
Outcomes: Autism Spectrum Disorder 
Methods
- Followed the navigation guide methodology to screen 
studies and assess them for risk of bias and quality
Figure 1. Prisma Graphic showing study  identification, screening, 
eligibility and inclusion 
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Rahbar et al., 
2017
High Probably Low High High High Low Low N/A Low Quality 
Shin et al., 2018 High Probably Low Low Probably High Probably Low Low Low Low High Quality 
Ponsonby et al., 
2020
High Probably Low Probably High High High Low Low Low Low Quality
Oulhote et al., 
2020
Probably high Low Low High Probably low Low Low Probably Low Moderate
Quality Assessment 
Quality Factor Rating Basis
Downgrade
Risk of Bias Across 
Studies
-1 There was a high risk of bias across studies, specifically in the exposure assessment 
Indirectness 0 The studies assessed the outcome, population, and exposure of interest. 
Inconsistency -1 There was variability in the results; one study showed a potential protective effect of DEHP on ASD, 
one showed no association, and the other showed moderate risk for adverse neurological outcomes.
Imprecision 0 All evaluated studies had an adequate sample size. Before stratification by sex. The confidence 
intervals were wide or straddled the null. 
Publication Bias 0 There was no reason to suspect publication bias 
Upgrade 
Large Magnitude of 
Effect
0 Studies either show no effect or a protective effect, will not upgrade
Dose Response 0 Evidence is not compelling enough to offer an upgrade 
Confounding 
minimizes effect
1 Two studies suggested that supplements during pregnancy were potentially protective factors
Overall Quality of 
Evidence 
0 Overall, the evidence does not support upgrading 
Summary of 
Qualitative Findings 
LOW The overall quality of evidence is low. Only one study was deemed to be of high quality and all studies 
did a poor job at assessing exposure. 
Results
- Most studies did not take a sufficient number of urine samples to 
adequately assess exposure
- There was downgrading due to inconsistency in results across studies 
while the other two studies showed no statistically significant effect. 
- All the evaluated studies suggested that prenatal supplements or folic 
acid intake during pregnancy potentially have an attenuating effect on 




Shin et al. 
(2018)
Cohort No increased risk for ASD with higher exposure to DEHP; 
There was a sex dependent association between high 
phthalate concentrations and non-typical development in 
males.
Oulhote et al. 
(2020) 
Cohort No observed association between gestational DEHP exposure 
and higher SRS scores, which are correlated with non-typical 
development. 
Ponsonby et al. 
(2020) 
Cohort They found that infants with high phthalate levels, including 
DEHP, were at moderate risk for an adverse neurological 
outcome but that the risk was substantially elevated if infants 
had a high gene score for oxidative stress and high phthalate 
exposure. 




Not-evaluated due to extremely low-quality study 
Conclusion and Recommendations 
Following an extensive review of the literature I found four 
studies that examined the potential influence of DEHP during 
gestation and early childhood on Autism incidence 
- Risk of bias of included studies was moderate
- This review shows potential evidence of DEHP exposure 
influencing ASD incidence.
- Due to the different statistics used for summarizing results and 
a lack of homogeneity between studies a meta-analysis could 
not be performed.
- There was low quality of evidence found across studies and a 
low number of studies included in review.
- The low-quality rating was driven primarily by poor exposure 
assessments; specifically, most studies used an insufficient 
number of urine samples to assess exposure which are likely 
only reflective of the last 6-12 hours of exposure to DEHP.
- Future cohort studies need to account for the potential 
variability in exposure across pregnancy and early childhood by 
taking many urine samples and pooling. 
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OTHER SOURCES OF BIAS
SUMMARY OF RISK BIAS
Low Probably Low Probably High High
